Want to join the conversation?
$TRV 2Q15 Q&A: Cohen of BofA asked about leverage deployment on M&A. Jay answered that we operate at the holding company with leverage target of somewhere in 15-25% range relative to total capital. TRV is running little under 22% at this point, consistent with ratings objective and discussion with rating agencies.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?